Home - Products - Others - Other Targets - 8-Hydroxy-3,5,6,7,3,4-hexamethoxyflavone

8-Hydroxy-3,5,6,7,3,4-hexamethoxyflavone

CAS No. 1000415-56-4

8-Hydroxy-3,5,6,7,3,4-hexamethoxyflavone( —— )

Catalog No. M31651 CAS No. 1000415-56-4

8-Hydroxy-3,5,6,7,3',4'-hexamethoxyflavone may have antifungal activity against phytopathogenic and human pathogenic fungi.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 495 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    8-Hydroxy-3,5,6,7,3,4-hexamethoxyflavone
  • Note
    Research use only, not for human use.
  • Brief Description
    8-Hydroxy-3,5,6,7,3',4'-hexamethoxyflavone may have antifungal activity against phytopathogenic and human pathogenic fungi.
  • Description
    8-Hydroxy-3,5,6,7,3',4'-hexamethoxyflavone may have antifungal activity against phytopathogenic and human pathogenic fungi.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1000415-56-4
  • Formula Weight
    418.39
  • Molecular Formula
    C21H22O9
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Vinyl Cinnamate

    Vinyl Cinnamate is a nartural product from Cinnamomum cassia Presl.

  • GSK2807 Trifluoroace...

    GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM).GSK2807, a potent and selective, SAM-competitive inhibitor of SMYD3 (Ki = 14 nM).?A high-resolution crystal structure reveals that GSK2807 bridges the gap between the SAM-binding pocket and the substrate lysine tunnel of SMYD3.

  • Lacutamab

    Lacutamab (IPH 4102) is a potent and selective humanized anti-KIR3DL2 antibody.Lacutamab has potential anticancer activity for the study of leukemia and lymphoma.